Abstract
Background Hepatitis C virus (HCV) infection continues to result in significant morbidity mortality in Australia. Eradication of challenge, with many the new era of direct-acting antivirals (DAAs), higher viral eradication rates are attainable, and access to treatment can be expanded by treating most patients practice, moving treatment by a gastroenterologist, physician. Currently available DAAs are pan-genotypic, well tolerated and safe; undertaken in general practice.
| Original language | English |
|---|---|
| Pages (from-to) | 697-701 |
| Number of pages | 5 |
| Journal | Australian Journal of General Practice |
| Volume | 50 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Blood-borne Virus
- Hepatitis C
- Infectious disease
- Liver
- Pharmacology
Fingerprint
Dive into the research topics of 'Treating chronic hepatitis C in general practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver